Table 1 Characteristics of patients with AIDS according to TB–HIV co-infection, São Paulo State, 2003 to 2014
Characteristics | TB–HIV co-infection | Total (n = 35,515) N (%) | p-value+ | |
|---|---|---|---|---|
No (n = 30,934) N (%) | Yes (n = 4581) N (%) | |||
Region of residence | < 0.001 | |||
SPC | 10,961 (35.4) | 1919 (41.9) | 12,880 (36.3) | |
GSPRa | 4798 (15.5) | 788 (17.2) | 5586 (15.7) | |
SPCA | 1720 (5.6) | 365 (8.0) | 2085 (5.9) | |
ISPS | 13,455 (43.5) | 1509 (32.9) | 14,964 (42.1) | |
Sex | < 0.001 | |||
Male | 18,964 (61.3) | 3403 (74.3) | 22,367 (63.0) | |
Female | 11,970 (38.7) | 1178 (25.7) | 13,148 (37.0) | |
Age group (years) | < 0.001 | |||
13 to 29 | 7378 (23.9) | 824 (18.0) | 8202 (23.1) | |
30 to 49 | 19,735 (63.8) | 3228 (70.5) | 22,963 (64.7) | |
≥ 50 | 3821 (12.4) | 529 (11.5) | 4350 (12.2) | |
Education (years of schooling)* | < 0.001 | |||
Illiterate | 577 (2.3) | 106 (3.0) | 683 (2.4) | |
1 to 3 | 2985 (11.7) | 528 (14.8) | 3513 (12.1) | |
4 to 7 | 9464 (37.2) | 1601 (45.0) | 11,065 (38.2) | |
8 to 11 | 9538 (37.5) | 1105 (31.1) | 10,643 (36.7) | |
≥ 12 | 2849 (11.2) | 216 (6.1) | 3065 (10.6) | |
Race/skin color** | < 0.001 | |||
White | 17,197 (65.4) | 2215 (57.5) | 19,412 (64.4) | |
Black | 6372 (24.2) | 1056 (27.4) | 7428 (24.6) | |
Mixed race/black | 2,567 (9.8) | 558 (14.5) | 3125 (10.4) | |
Yellow | 129 (0.5) | 18 (0.5) | 147 (0.5) | |
Indigenous | 33 (0.1) | 7 (0.2) | 40 (0.1) | |
Area of residence*** | 0.001 | |||
Urban | 29,288 (97.3) | 4267 (96.5) | 33,555 (97.2) | |
Rural | 658 (2.2) | 114 (2.6) | 772 (2.2) | |
Periurban | 161 (0.5) | 42 (0.9) | 203 (0.6) | |
Year of AIDS diagnosis | < 0.001 | |||
2003 | 7246 (23.4) | 1268 (27.7) | 8514 (24.0) | |
2004 | 6235 (20.2) | 985 (21.5) | 7220 (20.3) | |
2005 | 6213 (20.1) | 884 (19.3) | 7097 (20.0) | |
2006 | 5745 (18.6) | 761 (16.6) | 6506 (18.3) | |
2007 | 5495 (17.8) | 683 (14.9) | 6178 (17.4) | |
Exposure category | < 0.001 | |||
MSM | 6448 (23.0) | 712 (18.2) | 7160 (22.4) | |
Heterosexual | 18,599 (66.4) | 2379 (60.9) | 20,978 (65.7) | |
IDU | 2751 (9.8) | 788 (20.2) | 3539 (11.1) | |
CD4 (cells/mm3)***** | < 0.001 | |||
< 200 | 9530 (35.9) | 1698 (50.8) | 11,228 (37.6) | |
200–349 | 10,244 (38.6) | 954 (28.5) | 11,198 (37.5) | |
350–499 | 3194 (12.0) | 339 (10.1) | 3533 (11.8) | |
≥ 500 | 3543 (13.4) | 353 (10.6) | 3896 (13.0) | |
Viral load****** | < 0.001 | |||
≤ 500 | 3467 (14.2) | 512 (16.9) | 3979 (14.5) | |
> 500 | 20,864 (85.8) | 2517 (83.1) | 23,381 (85.5) | |
ARV regimenb | < 0.001 | |||
No ARV | 8235 (26.6) | 1838 (40.1) | 10,073 (28.4) | |
Pre-HAART | 27 (0.1) | 1 (0.0) | 28 (0.1) | |
HAART1 | 21,584 (69.8) | 2604 (56.8) | 24,188 (68.1) | |
HAART2 | 1088 (3.5) | 138 (3.0) | 1226 (3.5) | |